BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tan GH, Huang FY, Wang H, Huang YH, Lin YY, Li YN. Immunotherapy of hepatoma with a monoclonal antibody against murine endoglin. World J Gastroenterol 2007; 13(17): 2479-2483 [PMID: 17552032 DOI: 10.3748/wjg.v13.i17.2479]
URL: https://www.wjgnet.com/1948-5204/full/v13/i17/2479.htm
Number Citing Articles
1
E. Fonsatti, H. J.M. Nicolay, M. Altomonte, A. Covre, M. Maio. Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumoursCardiovascular Research 2010; 86(1): 12 doi: 10.1093/cvr/cvp332
2
Dafne Müller, Gerhard Trunk, Anke Sichelstiel, Kirstin A. Zettlitz, Miguel Quintanilla, Roland E. Kontermann. Murine endoglin-specific single-chain Fv fragments for the analysis of vascular targeting strategies in miceJournal of Immunological Methods 2008; 339(1): 90 doi: 10.1016/j.jim.2008.08.008
3
Pia Vihinen, Risto Ala-aho, Veli-Matti Kähäri. Diagnostic and prognostic role of matrix metalloproteases in cancerExpert Opinion on Medical Diagnostics 2008; 2(9): 1025 doi: 10.1517/17530059.2.9.1025
4
Monika Stimac, Tanja Dolinsek, Ursa Lampreht, Maja Cemazar, Gregor Sersa, Ilya Ulasov. Gene Electrotransfer of Plasmid with Tissue Specific Promoter Encoding shRNA against Endoglin Exerts Antitumor Efficacy against Murine TS/A Tumors by Vascular Targeted EffectsPLOS ONE 2015; 10(4): e0124913 doi: 10.1371/journal.pone.0124913
5
Aldona Kasprzak, Agnieszka Adamek. Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic TherapyInternational Journal of Molecular Sciences 2018; 19(12): 3887 doi: 10.3390/ijms19123887
6
Sun Young Kim, You Sun Kim, Hyun Tae Kim, Sun Ok Kwon, Myoung Ki Oh, In Hye Cha, Kyeong Sam Ok, Cheol Hun Kwak, Jin Nam Kim, Jeong Seop Moon. A Prospective Study of Factors Influencing on the Clinical Characteristics of Colonic DiverticulosisThe Korean Journal of Gastroenterology 2013; 62(2): 97 doi: 10.4166/kjg.2013.62.2.97